Upcoming: March 28, 2020 Livestream Online Conference for Prostate Cancer Patients: Mark Scholz, MD, comments on a segment of Lawrence Klotz's presentation concerning the "grey zone" wherein there is no unequivocal answer about whether a man's prostate cancer should be treated or observed. Dr. Klotz speaks on new research that shrinks the grey zone and Dr. Scholz explains how doctors who are trained to treat cancer (e.g. surgeons, radiation oncologists) will default to treatment when a case is in the grey zone. Dr. Scholz argues that patients should be educating themselves and making decisions for themselves about treatment when their case is in the grey zone.
Don’t know your prostate cancer stage? Take the quiz: Visit
To learn more about prostate cancer visit
To download the free Staging Guide visit
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#prostatecancer #laurenceklotzmd #activesurveillance
0 Comments